Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Dermatology

  Free Subscription


20.07.2026

5 BMC Cancer
7 Br J Dermatol
1 Cancer
1 Cancer Lett
2 Cancer Res
1 Clin Dermatol
9 Clin Exp Dermatol
1 Int J Cancer
4 Int J Dermatol
2 Intern Med
3 J Cutan Pathol
3 J Dermatol
5 J Invest Dermatol
6 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    BMC Cancer

  1. NGUYEN HT, Vu MD, Nguyen DD, Dinh PN, et al
    Next-generation sequencing-based characterization of BRCA1/2 variants across multiple tumor types in Vietnamese patients.
    BMC Cancer. 2026;26:858.
    PubMed         Abstract available

  2. OZTURK C, Cubukcu SS, Sen B, Ozturk AE, et al
    High TROP-2 expression as a predictor of poor neoadjuvant chemotherapy response in luminal B breast cancer: a retrospective clinicopathological study.
    BMC Cancer. 2026 May 23. doi: 10.1186/s12885-026-16227.
    PubMed         Abstract available

  3. CELIK O, Ozgul H, Kulaksizoglu S, Oner OZ, et al
    New biomarker in the early diagnosis of breast cancer: adiponectin, asprosin, adropin, and resistin.
    BMC Cancer. 2026 May 22. doi: 10.1186/s12885-026-16183.
    PubMed         Abstract available

  4. GUO X, Li P, Hu S, Ding Y, et al
    Real-world outcomes of CDK4/6 inhibitors in combination with endocrine therapy as first-line treatment for HR-positive/HER2-negative advanced breast cancer: multicenter evidence from China.
    BMC Cancer. 2026 May 20. doi: 10.1186/s12885-026-16176.
    PubMed         Abstract available

  5. KIRACI M, Soyturk G, Kos FT, Perkin P, et al
    Nailfold capillaroscopy findings after anthracycline-based chemotherapy and their association with subclinical changes in left ventricular ejection fraction.
    BMC Cancer. 2026;26:855.
    PubMed         Abstract available


    Br J Dermatol

  6. YILMAZ E, Ozer NK, Topal E
    Comment on 'Burden and risk of asthma and rhinitis in people with atopic dermatitis: global estimates from a hierarchical Bayesian model'.
    Br J Dermatol. 2026 Jul 15:ljag287. doi: 10.1093.
    PubMed        

  7. RUNGER A, Geusau A, Nageli M, Ferrandiz-Pulido C, et al
    Beyond the First Graft: Skin Cancer Risk and Risk Stratification in Retransplanted Solid Organ Recipients.
    Br J Dermatol. 2026 Jul 15:ljag286. doi: 10.1093.
    PubMed         Abstract available

  8. HADDADIN OM, Jacobson ME, Becker SL, Chen D, et al
    Minimum dataset for treatment effectiveness in pyoderma gangrenosum for an international registry: an international multidisciplinary eDelphi consensus.
    Br J Dermatol. 2026;195:270-279.
    PubMed         Abstract available

  9. YAO X, Liu Y, Luo Y, Liu X, et al
    Safety and efficacy of the selective tyrosine kinase 2/Janus kinase 1 inhibitor TLL-018 in patients with moderate-to-severe chronic spontaneous urticaria with inadequate response to H1 antihistamines: a phase Ib, randomized, double-blind, placebo-cont
    Br J Dermatol. 2026;195:222-231.
    PubMed         Abstract available

  10. KING B, Ehst B, Foley P, Reygagne P, et al
    Deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 inhibitor, in patients with alopecia areata: efficacy and safety results of a phase II, multicentre, randomized, double-blinded, placebo-controlled trial.
    Br J Dermatol. 2026;195:211-221.
    PubMed         Abstract available

  11. WANG S, Wang R, Yang Y, Dong Y, et al
    Transcriptome profiling reveals that cellular composition contributes to the hyaline-vascular variant in unicentric Castleman disease-associated paraneoplastic pemphigus.
    Br J Dermatol. 2026;195:304-315.
    PubMed         Abstract available

  12. CAO Z, Kong S, Ye J, Hu W, et al
    A clinically actionable stratification of bullous pemphigoid using a disease activity score reveals a targetable inflammatory endotype.
    Br J Dermatol. 2026;195:293-303.
    PubMed         Abstract available


    Cancer

  13. BAEKER BISPO J, Lee H, Tian J, Jemal A, et al
    Civic engagement and breast cancer screening participation among US citizens.
    Cancer. 2026;132:e70468.
    PubMed         Abstract available


    Cancer Lett

  14. LI J, Yang D, Lv R, Jin Y, et al
    Single-cell mapping of extrachromosomal circular DNA architecture and evolution in cutaneous squamous cell carcinoma.
    Cancer Lett. 2026;658:218735.
    PubMed         Abstract available


    Cancer Res

  15. YOUNG RG, Esquea EM, Ciraku L, Merzy J, et al
    ACSS2 Suppresses Ferroptosis to Drive Breast Cancer Brain Metastasis.
    Cancer Res. 2026 Apr 22. doi: 10.1158/0008-5472.CAN-25-3006.
    PubMed         Abstract available

  16. SHER EF, Fujihara KM, Tao A, Sastourne-Haletou P, et al
    Targeting DNA Polymerase Epsilon Induces Tumor Clearance and Activates an NF-kappaB-Mediated Inflammatory Response in Triple Negative Breast Cancer.
    Cancer Res. 2026 Apr 21. doi: 10.1158/0008-5472.CAN-25-2217.
    PubMed         Abstract available


    Clin Dermatol

  17. YIGIT IK, Tursen U, Kroumpouzos G
    Topical Melatonin in Aesthetic Dermatology: From Cutaneous Melatoninergic Biology to Photoprotection, and Skin Rejuvenation.
    Clin Dermatol. 2026 Jul 11:S0738-081X(26)00182.
    PubMed         Abstract available


    Clin Exp Dermatol

  18. YILMAZ E, Ozer NK, Topal E
    Comment on 'Lebrikizumab provides stable skin response with no or minimal fluctuations for up to 2 years in patients with atopic dermatitis'.
    Clin Exp Dermatol. 2026 Jul 13:llag298. doi: 10.1093.
    PubMed        

  19. WANG X
    Diffuse pruritic erythematous lichenification of the scrotum.
    Clin Exp Dermatol. 2026 Jul 14:llag290. doi: 10.1093.
    PubMed        

  20. SUN R, Liu X, Wu J
    Comment on 'Clinical phenotype of 504 pustular psoriasis patients from Europe and Egypt: a multi-center observational study'.
    Clin Exp Dermatol. 2026 Jul 14:llag293. doi: 10.1093.
    PubMed        

  21. HAN SJ, Aung AK
    Comment on 'Cardiac involvement in severe cutaneous adverse reactions: a Retrospective Observational Cohort Study of DRESS and SJS/TEN at a major Australian tertiary hospital': reply from authors.
    Clin Exp Dermatol. 2026 Jul 14:llag294. doi: 10.1093.
    PubMed        

  22. YILMAZ E, Ozer NK, Topal E
    Comment on 'Long-term effectiveness of bimekizumab in plaque psoriasis: 2-year drug survival from a real-life multicenter Italian study'.
    Clin Exp Dermatol. 2026 Jul 15:llag297. doi: 10.1093.
    PubMed        

  23. GULLIVER WP, Perlmutter JW, Gulliver SR, Tiplica GS, et al
    Long-term Remission of Severe Psoriasis Following CD19 CAR-T Cell Therapy for Follicular Lymphoma.
    Clin Exp Dermatol. 2026 Jul 16:llag301. doi: 10.1093.
    PubMed         Abstract available

  24. LLOYD E, Beck-Sander K, Chong W, Belgi A, et al
    Not Every Purple Plaque Is Recurrence: A Striking Skin Eruption on a Melanoma Skin Graft Site.
    Clin Exp Dermatol. 2026 Jul 17:llag306. doi: 10.1093.
    PubMed        

  25. PATHAK GN, Syed A, Pathak SS, Tan B, et al
    Pemphigoid was not associated with increased risk of solid organ, hematologic, or nonmelanoma skin malignancies in a nationally representative matched cohort.
    Clin Exp Dermatol. 2026 Jul 17:llag312. doi: 10.1093.
    PubMed        

  26. HAMID I, Hussain K, Patel NP
    Missed melanoma following skin lesion triage by an autonomous artificial intelligence system in a community setting.
    Clin Exp Dermatol. 2026 Jul 17:llag314. doi: 10.1093.
    PubMed        


    Int J Cancer

  27. KOTT J, Geidel G, Roeper CMT, Ackar L, et al
    Unraveling the Plasma Extracellular Vesicles Proteome: Predictors of Resistance in Immunotherapy of Advanced Melanoma.
    Int J Cancer. 2026 Jul 12. doi: 10.1002/ijc.70650.
    PubMed         Abstract available


    Int J Dermatol

  28. KOUMAKI D, Koumprentziotis IA, Apalla Z, Sibaud V, et al
    Effectiveness and Safety of Apremilast in Immune Checkpoint Inhibitor-Associated Psoriasis: A Retrospective Multicenter Study From the EADV Task Force "Dermatology for Cancer Patients".
    Int J Dermatol. 2026 Jul 16. doi: 10.1111/ijd.70592.
    PubMed        

  29. SORRENTINO P, Malaspina M, Scharf C, Nicoletti MM, et al
    Granular Cell Tumor Mimicking Common Skin Neoplasms: Two Cases Highlighting a Shared Dermoscopic Clue.
    Int J Dermatol. 2026 Jul 15. doi: 10.1111/ijd.70578.
    PubMed        

  30. LITAIEM N, Akid M, Boudaya S, Zaouak A, et al
    Severity of Psoriasis in Tunisia: Cross-Sectional Results From the National PsoTReg Registry.
    Int J Dermatol. 2026 Jul 14. doi: 10.1111/ijd.70589.
    PubMed         Abstract available

  31. MINAKAWA S, Higashino T, Nakagawa J, Ogasawara S, et al
    Follicular Lymphoma Developing During IL-17A Inhibitor Therapy in a Patient With Psoriasis: Retreatment Without Lymphoma Progression.
    Int J Dermatol. 2026 Jul 14. doi: 10.1111/ijd.70587.
    PubMed        


    Intern Med

  32. TAKAHASHI H, Hatayama S, Izumi T
    Characteristic Glycemic Patterns during Capivasertib Treatment Identified by Continuous Glucose Monitoring.
    Intern Med. 2026;65:1937-1942.
    PubMed         Abstract available

  33. YAMAMOTO M, Dembo T, Yamaga T, Momose S, et al
    The Use of Vessel Wall Imaging for Making an Early Diagnosis of Giant Cell Arteritis in a Case with Cerebral Infarction.
    Intern Med. 2025 Dec 11. doi: 10.2169/internalmedicine.6532.
    PubMed         Abstract available


    J Cutan Pathol

  34. REBOUL H, Thibaut I, Galinier P, Tournier E, et al
    A PRKCA-Fused Blue Melanocytoma Expressing a Truncated ALK Isoform.
    J Cutan Pathol. 2026 Jul 10. doi: 10.1111/cup.70171.
    PubMed         Abstract available

  35. PEI S, Fung MA, Piliang M, Rubin AI, et al
    Kratom Cutaneous Hyperpigmentation: An Emerging Dermatosis for Dermatopathologists and Dermatologists to Recognize.
    J Cutan Pathol. 2026 Jul 12. doi: 10.1111/cup.70175.
    PubMed        

  36. PATEL S, Graham B, Reaves K, Phelps M, et al
    Histopathologic Characterization of Cutaneous Oxalosis Mimicking Calciphylaxis: Diagnostic Pitfalls and Polarized Light Evaluation.
    J Cutan Pathol. 2026 Jul 13. doi: 10.1111/cup.70177.
    PubMed         Abstract available


    J Dermatol

  37. KANAYA M, Mitsui Y, Sasaki S, Ochi A, et al
    Granulomatous Vasculitis in Cutaneous Hydrophilic Polymer Embolism.
    J Dermatol. 2026 Jul 17. doi: 10.1111/1346-8138.70376.
    PubMed         Abstract available

  38. OKUDA K, Nakamura M, Nakamura R, Takagi S, et al
    Early Intervention Effects and Risk Factors for Residual Skin Changes in Infantile Hemangiomas.
    J Dermatol. 2026 Jul 16. doi: 10.1111/1346-8138.70388.
    PubMed         Abstract available

  39. YAMAI T, Yamamoto-Hanada K, Yonemichi H, Yamamoto S, et al
    Restraint-Free Initiation of Dupilumab in a Child With Autism Spectrum Disorder: Overcoming Procedural Barriers in Atopic Dermatitis.
    J Dermatol. 2026 Jul 14. doi: 10.1111/1346-8138.70394.
    PubMed         Abstract available


    J Invest Dermatol

  40. JAISWAL A, Kim E, Yildiz-Altay U, Breidbart R, et al
    Differential expression of immune checkpoint VISTA in inflammatory skin diseases.
    J Invest Dermatol. 2026 Jul 15:S0022-202X(26)02675.
    PubMed        

  41. NAMINI MRJ, Nielsen PR, Gluud M, Yan L, et al
    Malignant T Cells Operate at the Edge of Redox Tolerance and Propagate Oxidative Stress in Cutaneous T-Cell Lymphoma.
    J Invest Dermatol. 2026 Jul 13:S0022-202X(26)02673.
    PubMed         Abstract available

  42. PIFFAUT V, Renoux P, Douezan S, Lima L, et al
    Visible Light-Induced Pigmentation: Exploring Variations Across Skin Phototypes and Ancestries.
    J Invest Dermatol. 2026 Jul 13:S0022-202X(26)02674.
    PubMed        

  43. QUAN I, Carstens LY, Lio P
    Association Between Household Endotoxin Exposure and Atopic Dermatitis: A Cross-Sectional U.S.-Based Population Study.
    J Invest Dermatol. 2026 Jul 11:S0022-202X(26)02670.
    PubMed        

  44. CHEN MK, Haran K, Diaz MJ, Orcales F, et al
    Clinical and genetic characterization of genital and inverse psoriasis as a distinct psoriasis endotype.
    J Invest Dermatol. 2026 Jul 11:S0022-202X(26)02672.
    PubMed        


    PLoS One

  45. NIE S, Liu D, Hu J, Gan Y, et al
    TBX20 promotes doxorubicin resistance in breast cancer cells through enhanced ABCC1 expression and inhibition of mitophagy.
    PLoS One. 2026;21:e0353376.
    PubMed         Abstract available

  46. MA C, Sun J, Liu Z, Zhang C, et al
    Skin manifestations of primary COVID-19 infection with the omicron variant.
    PLoS One. 2026;21:e0352201.
    PubMed         Abstract available

  47. MAENPAA N, Tiainen L, Martikainen J, Tanner M, et al
    Real-world implementation and cost impact analysis of Oncotype DX testing in early-stage breast cancer.
    PLoS One. 2026;21:e0353941.
    PubMed         Abstract available

  48. RAO NT, Ramana CVV, Karim FK, Aljarbouh A, et al
    ViT-MultiRAGNet: A scalable and reliable retrieval-augmented Vision Transformer framework for memory-guided feature fusion multi-modal mammogram classification.
    PLoS One. 2026;21:e0349865.
    PubMed         Abstract available

  49. GOLDSBURY DE, Cust AE, Watts C, Pearce A, et al
    Health system costs and systemic treatment patterns by disease stage for 8577 people diagnosed with melanoma in New South Wales, Australia 2006-2019.
    PLoS One. 2026;21:e0353408.
    PubMed         Abstract available

  50. WANG W, Zhang Q, Xu S
    Transcriptomic characterization of key psoriasis-associated genes based on single-cell RNA-seq and machine learning.
    PLoS One. 2026;21:e0352663.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Dermatology is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum